192726-06-0 Usage
General Description
N-(4-Amino-1-benzyl-3-hydroxy-5-phenyl-pentyl)-3-methyl-2-(2-oxo-tetrahydro-pyrimidin-1-yl)-butyramide 5-oxopyrrolidine-2-carboxylic acid is a complex chemical compound. Its structure includes several important functional groups such as the amino group, the hydroxy group, the phenyl group, and the carboxylic acid group, among others. Its long name indicates the presence of a benzyl group, a phenyl group and a pyrimidinyl group which are common in various pharmaceuticals. Detailed information such as its exact molecular structure, physical and chemical properties, potential applications, toxicity, and synthetic procedures is not readily available but may be potentially researched or studied as per specific scientific interest or application. Generally, analytical methods like NMR, IR, and mass spectroscopy would be essential to identify and characterize such a complex molecule.
Check Digit Verification of cas no
The CAS Registry Mumber 192726-06-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,2,7,2 and 6 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 192726-06:
(8*1)+(7*9)+(6*2)+(5*7)+(4*2)+(3*6)+(2*0)+(1*6)=150
150 % 10 = 0
So 192726-06-0 is a valid CAS Registry Number.
192726-06-0Relevant articles and documents
AN IMPROVED PROCESS FOR PREPARATION OF LOPINAVIR AND ITS INTERMEDIATES THEREOF
-
, (2019/10/23)
The present invention generally relates to an improved process for preparation of lopinavir and its intermediates through formation of tartrate salt of compound of Formula (III).
AN IMPROVED PROCESS FOR THE PREPARATION OF SUBSTANTIALLY PURE (2S,3S,5S)-5-AMINO-2-N,N-DIBENZYLAMINO-3-HYDROXY-1,6-DIPHENYLHEXANE
-
Page/Page column 11; 14, (2009/01/24)
The present invention relates to the purification of (2S,3S,5S)-5-amino-2-N,N-dibenzylamino-3-hydroxy-1,6-diphenylhexane (III) by making its crystalline acid addition salt, which can be used as such to produce Lopinavir /Ritonavir with high purity and yield. Formula III
Retroviral protease inhibiting compounds
-
Page 65, (2010/01/31)
A compound comprising a substituent of the formula (II) is disclosed as an HIV protease inhibitor. Intermediates for making such compounds and processes for making such intermediates are also disclosed.